1. Home
  2. BLNK vs NKTX Comparison

BLNK vs NKTX Comparison

Compare BLNK & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLNK
  • NKTX
  • Stock Information
  • Founded
  • BLNK 2009
  • NKTX 2015
  • Country
  • BLNK United States
  • NKTX United States
  • Employees
  • BLNK N/A
  • NKTX N/A
  • Industry
  • BLNK Industrial Specialties
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLNK Consumer Discretionary
  • NKTX Health Care
  • Exchange
  • BLNK Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • BLNK 77.3M
  • NKTX 123.5M
  • IPO Year
  • BLNK N/A
  • NKTX 2020
  • Fundamental
  • Price
  • BLNK $0.97
  • NKTX $1.80
  • Analyst Decision
  • BLNK Buy
  • NKTX Strong Buy
  • Analyst Count
  • BLNK 8
  • NKTX 6
  • Target Price
  • BLNK $2.61
  • NKTX $14.40
  • AVG Volume (30 Days)
  • BLNK 4.3M
  • NKTX 434.5K
  • Earning Date
  • BLNK 08-06-2025
  • NKTX 08-12-2025
  • Dividend Yield
  • BLNK N/A
  • NKTX N/A
  • EPS Growth
  • BLNK N/A
  • NKTX N/A
  • EPS
  • BLNK N/A
  • NKTX N/A
  • Revenue
  • BLNK $109,383,000.00
  • NKTX N/A
  • Revenue This Year
  • BLNK N/A
  • NKTX N/A
  • Revenue Next Year
  • BLNK $31.15
  • NKTX N/A
  • P/E Ratio
  • BLNK N/A
  • NKTX N/A
  • Revenue Growth
  • BLNK N/A
  • NKTX N/A
  • 52 Week Low
  • BLNK $0.63
  • NKTX $1.31
  • 52 Week High
  • BLNK $3.75
  • NKTX $8.23
  • Technical
  • Relative Strength Index (RSI)
  • BLNK 55.64
  • NKTX 51.45
  • Support Level
  • BLNK $0.88
  • NKTX $1.68
  • Resistance Level
  • BLNK $1.10
  • NKTX $1.84
  • Average True Range (ATR)
  • BLNK 0.08
  • NKTX 0.08
  • MACD
  • BLNK 0.00
  • NKTX 0.01
  • Stochastic Oscillator
  • BLNK 56.43
  • NKTX 80.95

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: